Annual Current Assets
$153.11 M
-$162.13 M-51.43%
31 December 2023
Summary:
Inovio Pharmaceuticals annual total current assets is currently $153.11 million, with the most recent change of -$162.13 million (-51.43%) on 31 December 2023. During the last 3 years, it has fallen by -$318.06 million (-67.50%). INO annual current assets is now -67.50% below its all-time high of $471.17 million, reached on 31 December 2020.INO Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$91.28 M
-$26.28 M-22.35%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly total current assets is currently $91.28 million, with the most recent change of -$26.28 million (-22.35%) on 30 September 2024. Over the past year, it has dropped by -$83.48 million (-47.77%). INO quarterly current assets is now -84.49% below its all-time high of $588.43 million, reached on 31 March 2021.INO Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -51.4% | -47.8% |
3 y3 years | -67.5% | -81.3% |
5 y5 years | +74.4% | -7.6% |
INO Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -67.5% | at low | -81.3% | at low |
5 y | 5 years | -67.5% | +74.4% | -84.5% | at low |
alltime | all time | -67.5% | +5575.3% | -84.5% | +8254.8% |
Inovio Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $91.28 M(-22.4%) |
June 2024 | - | $117.56 M(+5.3%) |
Mar 2024 | - | $111.68 M(-27.1%) |
Dec 2023 | $17.84 M(-46.4%) | $153.11 M(-12.4%) |
Sept 2023 | - | $174.77 M(-14.0%) |
June 2023 | - | $203.28 M(-13.1%) |
Mar 2023 | - | $233.90 M(-25.8%) |
Dec 2022 | $33.29 M(-29.9%) | $315.24 M(-10.0%) |
Sept 2022 | - | $350.21 M(-15.9%) |
June 2022 | - | $416.19 M(+4.1%) |
Mar 2022 | - | $399.91 M(-10.8%) |
Dec 2021 | $47.50 M(-30.8%) | $448.44 M(-8.0%) |
Sept 2021 | - | $487.40 M(-10.1%) |
June 2021 | - | $542.42 M(-7.8%) |
Mar 2021 | - | $588.43 M(+24.9%) |
Dec 2020 | $68.60 M(+37.9%) | $471.17 M(+25.0%) |
Sept 2020 | - | $377.06 M(-1.3%) |
June 2020 | - | $382.06 M(+38.7%) |
Mar 2020 | - | $275.54 M(+192.5%) |
Dec 2019 | $49.75 M(+14.9%) | $94.20 M(-4.7%) |
Sept 2019 | - | $98.81 M(-10.6%) |
June 2019 | - | $110.51 M(-18.1%) |
Mar 2019 | - | $134.90 M(+53.6%) |
Dec 2018 | $43.30 M(-11.4%) | $87.81 M(-6.2%) |
Sept 2018 | - | $93.60 M(-8.1%) |
June 2018 | - | $101.84 M(-17.8%) |
Mar 2018 | - | $123.84 M(-10.5%) |
Dec 2017 | $48.88 M(-0.5%) | $138.36 M(-10.5%) |
Sept 2017 | - | $154.59 M(+44.6%) |
June 2017 | - | $106.88 M(+0.1%) |
Mar 2017 | - | $106.78 M(-14.3%) |
Dec 2016 | $49.11 M(+17.0%) | $124.60 M(-11.1%) |
Sept 2016 | - | $140.23 M(-5.2%) |
June 2016 | - | $147.97 M(-7.9%) |
Mar 2016 | - | $160.60 M(-6.5%) |
Dec 2015 | $41.99 M(+27.9%) | $171.85 M(-6.6%) |
Sept 2015 | - | $184.07 M(+13.5%) |
June 2015 | - | $162.14 M(+85.7%) |
Mar 2015 | - | $87.33 M(-11.7%) |
Dec 2014 | $32.84 M(+10.9%) | $98.95 M(-5.4%) |
Sept 2014 | - | $104.64 M(-7.4%) |
June 2014 | - | $112.94 M(-7.2%) |
Mar 2014 | - | $121.68 M(+107.4%) |
Dec 2013 | $29.60 M(+1.5%) | $58.68 M(+1.4%) |
Sept 2013 | - | $57.85 M(+126.6%) |
June 2013 | - | $25.54 M(-15.8%) |
Mar 2013 | - | $30.32 M(+89.9%) |
Dec 2012 | $29.17 M(-0.1%) | $15.97 M(-5.7%) |
Sept 2012 | - | $16.93 M(-20.6%) |
June 2012 | - | $21.32 M(-20.9%) |
Mar 2012 | - | $26.94 M(-15.6%) |
Dec 2011 | $29.20 M | $31.91 M(-2.5%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2011 | - | $32.73 M(-15.2%) |
June 2011 | - | $38.61 M(-9.1%) |
Mar 2011 | - | $42.48 M(+85.7%) |
Dec 2010 | $33.19 M(-8.0%) | $22.88 M(-5.7%) |
Sept 2010 | - | $24.27 M(-11.1%) |
June 2010 | - | $27.32 M(-36.7%) |
Mar 2010 | - | $43.12 M(-3.2%) |
Dec 2009 | $36.06 M(+52.0%) | $44.57 M(-8.0%) |
Sept 2009 | - | $48.43 M(+99.6%) |
June 2009 | - | $24.26 M(+95.2%) |
Mar 2009 | - | $12.42 M(-18.6%) |
Dec 2008 | $23.72 M(+120.3%) | $15.26 M(+93.2%) |
Sept 2008 | - | $7.90 M(-14.4%) |
June 2008 | - | $9.23 M(-25.4%) |
Mar 2008 | - | $12.37 M(-57.4%) |
Dec 2007 | $10.77 M(-6.2%) | $29.00 M(-2.1%) |
Sept 2007 | - | $29.62 M(-10.2%) |
June 2007 | - | $32.99 M(+61.5%) |
Mar 2007 | - | $20.43 M(-16.5%) |
Dec 2006 | $11.48 M(+7.7%) | $24.47 M(+168.9%) |
Sept 2006 | - | $9.10 M(-25.0%) |
June 2006 | - | $12.14 M(-20.6%) |
Mar 2006 | - | $15.29 M(-16.5%) |
Dec 2005 | $10.66 M(+324.1%) | $18.32 M(+196.1%) |
Sept 2005 | - | $6.19 M(-40.1%) |
June 2005 | - | $10.33 M(-20.5%) |
Mar 2005 | - | $12.99 M(-29.6%) |
Dec 2004 | $2.51 M(+1.4%) | $18.44 M(-8.7%) |
Sept 2004 | - | $20.20 M(-9.2%) |
June 2004 | - | $22.24 M(+68.3%) |
Mar 2004 | - | $13.22 M(-3.9%) |
Dec 2003 | $2.48 M(-9.0%) | $13.75 M(+84.9%) |
Sept 2003 | - | $7.44 M(+580.8%) |
June 2003 | - | $1.09 M(-53.6%) |
Mar 2003 | - | $2.36 M(-12.6%) |
Dec 2002 | $2.72 M(-10.1%) | $2.70 M(-29.6%) |
Sept 2002 | - | $3.83 M(-25.1%) |
June 2002 | - | $5.11 M(+122.9%) |
Mar 2002 | - | $2.29 M(-40.7%) |
Dec 2001 | $3.03 M(-6.5%) | - |
Sept 2001 | - | $3.87 M(-33.0%) |
June 2001 | - | $5.77 M(-30.0%) |
Mar 2001 | - | $8.25 M(+41.7%) |
Mar 2001 | $3.24 M(+35.0%) | - |
Dec 2000 | - | $5.82 M(-27.7%) |
Sept 2000 | - | $8.05 M(-21.8%) |
June 2000 | - | $10.29 M(-11.4%) |
Mar 2000 | $2.40 M(+8.6%) | $11.61 M(-10.0%) |
Dec 1999 | - | $12.90 M(-10.4%) |
Sept 1999 | - | $14.40 M(-9.4%) |
June 1999 | - | $15.90 M(+109.2%) |
Mar 1999 | $2.21 M | $7.60 M(-23.2%) |
Dec 1998 | - | $9.90 M |
FAQ
- What is Inovio Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual current assets year-on-year change?
- What is Inovio Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly current assets year-on-year change?
What is Inovio Pharmaceuticals annual total current assets?
The current annual current assets of INO is $153.11 M
What is the all time high annual current assets for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual total current assets is $471.17 M
What is Inovio Pharmaceuticals annual current assets year-on-year change?
Over the past year, INO annual total current assets has changed by -$162.13 M (-51.43%)
What is Inovio Pharmaceuticals quarterly total current assets?
The current quarterly current assets of INO is $91.28 M
What is the all time high quarterly current assets for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly total current assets is $588.43 M
What is Inovio Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, INO quarterly total current assets has changed by -$83.48 M (-47.77%)